Acquisition Adds 50,000+ HCPs to Global Research Panel
NEW YORK, NY — June 15, 2021 — Sermo, the world’s leading HCP insights company and the first social media platform for physicians, today announced its acquisition of Australia-based market research leader, Minter Group. The acquisition expands Sermo’s existing panel of 1.3M physicians to include an additional 50,000+ Asia-Pacific (APAC)-based HCPs, and aims to better connect the pharmaceutical industry to HCPs in emerging markets.
Since 2003 Minter has built a variety of research panels across various industries including IT, consumer and healthcare. For the pharmaceutical and biotech industries, Minter employs multilingual HCPs and research facilitators across multiple specialties servicing clients such as Ipsos and Optimal Strategix.
In addition to enhanced opportunities to participate in market research, Minter HCPs will now have access to Sermo’s social platform benefits including medical crowdsourcing capabilities, the world’s largest database of 1M peer-to-peer physician drug ratings, specialty-specific educational content from industry and much more.
“The rise of chronic conditions and aging populations in the APAC region, combined with the fact that Southeast Asia is becoming one of the fastest growing pharmaceutical markets in the world, means the need for HCP insights with the potential to help deliver safe and effective treatment options to patients has never been greater,” said Peter Kirk, Sermo CEO. “We’re excited to welcome Minter customers into a larger global initiative to amplify the voice of physicians and ultimately, support better patient outcomes.”
Sermo turns physician experience, expertise, and observations into actionable insights for the global healthcare community. Engaging with more than 1.3 million HCPs across 150 countries, the company provides physicians with a social platform and unique community that fosters impactful peer-to-peer collaboration & discussions about issues that are important to them and their patients. Sermo offers on demand access to physicians via a suite of proprietary technology to provide business intelligence that benefits pharmaceutical, healthcare partners, and the medical community at large. To learn more, visit www.sermo.com
Media Contact: firstname.lastname@example.org